Marshall Wace, LLP Grifols Sa Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $2.95 Million - $4.41 Million	-288,905 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $195,207 - $240,020	13,874 Added 5.04%	288,905 $4.22 Million
Q2 2021 Aug 13, 2021	SELL	$16.62 - $18.94 $10 Million - $11.4 Million	-604,527 Reduced 68.73%	275,031 $4.77 Million
Q1 2021 May 17, 2021	SELL	$15.15 - $19.78 $2.55 Million - $3.33 Million	-168,314 Reduced 16.06%	879,558 $15.2 Million
Q4 2020 Feb 16, 2021	SELL	$16.86 - $19.67 $1.8 Million - $2.1 Million	-106,537 Reduced 9.23%	1,047,872 $19.3 Million
Q3 2020 Nov 16, 2020	BUY	$15.4 - $20.16 $9.17 Million - $12 Million	595,726 Added 106.63%	1,154,409 $20 Million
Q2 2020 Aug 13, 2020	SELL	$18.24 - $21.45 $8.35 Million - $9.82 Million	-457,603 Reduced 45.03%	558,683 $10.2 Million
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $3.05 Million - $4.8 Million	-187,333 Reduced 15.56%	1,016,286 $20.5 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $23.52 $7.47 Million - $8.98 Million	381,935 Added 46.48%	1,203,619 $28 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $3.72 Million - $4.27 Million	187,633 Added 29.59%	821,684 $16.5 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $8.8 Million - $10.6 Million	500,553 Added 374.95%	634,051 $13.4 Million
Q1 2019 May 14, 2019	BUY	$18.01 - $20.11 $2.07 Million - $2.32 Million	115,170 Added 628.38%	133,498 $2.69 Million
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $2.23 Million - $2.76 Million	-128,010 Reduced 87.48%	18,328 $336,000
Q3 2018 Nov 14, 2018	BUY	$19.97 - $21.96 $2.49 Million - $2.74 Million	124,590 Added 572.88%	146,338 $3.13 Million
Q2 2018 Aug 14, 2018	SELL	$20.16 - $24.68 $384,148 - $470,277	-19,055 Reduced 46.7%	21,748 $468,000
Q1 2018 May 15, 2018	SELL	$20.31 - $24.95 $238,053 - $292,438	-11,721 Reduced 22.32%	40,803 $865,000
Q4 2017 Feb 14, 2018	SELL	$20.99 - $23.89 $16.9 Million - $19.3 Million	-806,774 Reduced 93.89%	52,524 $1.2 Million
Q3 2017 Nov 13, 2017	BUY	$20.07 - $21.89 $17.2 Million - $18.8 Million	859,298	859,298 $18.9 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

Capital World Investors Los Angeles, CA

21M
Shares

$164 Million
0.03% of portfolio
Brandes Investment Partners, LP La Jolla, CA

19.9M
Shares

$156 Million
2.11% of portfolio
Permian Investment Partners, LP New York, NY

12.3M
Shares

$96.4 Million
16.06% of portfolio
Black Creek Investment Management Inc. Toronto, A6

11.1M
Shares

$86.9 Million
3.5% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

10.7M
Shares

$83.9 Million
0.05% of portfolio

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account